Skip to main content
Figure 5 | Molecular Cancer

Figure 5

From: A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

Figure 5

Risk factors and survival of 72 MYCN not amplified patients. Patients are divided in poor and good prognosis groups according to the NB-hypo. Columns represent individual patients. The first line represents the patients according to the International Neuroblastoma Staging System (INSS). The second line represents the patients according to the age at diagnosis (> 1 year vs. < 1 year). In the last line, the patients are divided in deceased, black squares, and alive, gray squares.

Back to article page

Molecular Cancer

ISSN: 1476-4598